Quantcast

Latest Temporal lobe epilepsy Stories

2009-05-26 11:09:00

- New antiepileptic drug with novel mechanism of action helps address critical unmet medical need for many people living with uncontrolled epilepsy - Vimpat(R) offers hope to people with epilepsy who still have uncontrolled partial onset seizures with current treatment ATLANTA, May 26 /PRNewswire/ -- press release, regulated information - UCB today announced that Vimpat(R) (lacosamide) C-V, a new antiepileptic drug (AED) is available in the U.S. as an add-on therapy for the treatment of...

2009-05-18 17:59:15

U.S. experts said a technology being developed for use in diagnosing brain issues could eliminate costly and invasive pre-surgery for epilepsy patients. Susumu Sato, a physician and researcher with the National Institute of Neurological Disorders and Stroke within the National Institutes of Health, said epilepsy patients often must undergo a pre-surgery procedure that involves removing a portion of the patient's skull and temporarily placing electrodes on the surface of the brain to detect...

2009-01-27 07:00:00

- Vimpat(R) demonstrated greater seizure reduction and improved seizure freedom versus placebo when added to first and second-generation antiepileptic drugs (AEDs) - Phase III study supports recent U.S. FDA and European Commission approvals of Vimpat(R) ATLANTA, Jan. 27 /PRNewswire-FirstCall/ -- The new antiepileptic drug Vimpat(R) (lacosamide) demonstrated significantly fewer seizures in adult partial-onset epilepsy patients whose seizures were inadequately controlled despite taking up to...

2008-10-29 03:00:14

* New antiepileptic drug with a novel mechanism of action * Vimpat(R) helped people with epilepsy who still had uncontrolled partial onset seizures with current treatment * Vimpat(R) will be available in the U.S. as oral tablets and intravenous (IV) infusion * Vimpat(R) should be launched in the U.S. early 2009 by the well-established UCB epilepsy team Brussels, BELGIUM, October 29, 2008 at 7:00 CET- press release, regulated information - UCB announced today that the...

2008-09-05 06:00:23

Belgium-based biopharmaceutical and specialty chemical company UCB has announced that the European Commission has approved Vimpat as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older. The European Commission approval is based on data from three multicenter, randomized, placebo-controlled clinical trials that evaluated the efficacy and safety of Vimpat adjunctive treatment in over 1,300...

2008-09-03 03:00:24

First New Epilepsy Treatment for Partial-Onset Seizures in Three Years * A novel mode of action * Improved seizure control when added to a wide range of antiepileptic drugs * High long-term retention rate * Multiple formulations for ease of use * Soon to be launched in Germany and the UK Brussels, BELGIUM - September 3, 2008 at 7:00 am CEST - press release, regulated information: UCB announced today that the European Commission (EC) has approved Vimpat(R) (lacosamide) as...

2008-06-26 15:00:48

Press release: regulated information UCB announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending that the European Commission grants a marketing authorisation for lacosamide, proposed trade name Vimpat(TM), for the adjunctive treatment of partial onset seizures with or without secondary generalisation in patients with epilepsy, aged 16 years and older. The recommendation has been...

2006-12-05 18:02:09

By ED SUSMAN So-called Gamma Knife surgery -- focusing radiation to one point in the brain -- offers an alternative to open surgery for one of the most common forms of epilepsy. We had a 67 percent overall success rate in giving patients freedom from seizures after two years following Gamma Knife surgery, said Mark Quigg, associate professor of neurology at the University of Virginia in Charlottesville. Quigg recruited 30 patients diagnosed with mesial temporal lobe epilepsy, usually...

2005-12-12 16:57:56

NEW YORK (Reuters Health) - In patients with epilepsy that does not respond to drug therapy, and who also have depression or anxiety, surgery to treat the epilepsy often results in improvements in psychiatric symptoms, according to results of a multicenter study. Depression and anxiety are common among patients with epilepsy, Dr. Orrin Devinsky, from the New York University School of Medicine, and his co-investigators note in the journal Neurology. They followed 360 patients after...

2005-09-21 16:26:35

San Diego -- Positron emission tomography (PET) brain scans of a brain chemical messenger system may prove sensitive enough to help plan brain surgery for epilepsy, according to a study presented at the 130th annual meeting of the American Neurological Association in San Diego. "Our preliminary data suggest that PET imaging with a marker that shows deficits in signaling for the neurotransmitter serotonin is more sensitive than the traditional PET measurement of brain glucose," said senior...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related